The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses

注册号:

Registration number:

ChiCTR2600116017 

最近更新日期:

Date of Last Refreshed on:

2026-01-04 16:41:24 

注册时间:

Date of Registration:

2026-01-04 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses

Public title:

The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses

注册题目简写:

English Acronym:

研究课题的正式科学名称:

The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses

Scientific title:

The Effects of Low‐ and High‐Glycemic Index Sport Nutrition Bars on Metabolism and High‐Intensity Interval Training Responses

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

ZHANG Borui 

研究负责人:

ZHANG Borui 

Applicant:

ZHANG Borui 

Study leader:

ZHANG Borui 

申请注册联系人电话:

Applicant telephone:

+852 3943 6085

研究负责人电话:

Study leader's
telephone:

+852 3943 6085

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

boruizhang@cuhk.edu.hk

研究负责人电子邮件:

Study leader's E-mail:

boruizhang@cuhk.edu.hk

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

G02, Kwok Sports Building, The Chinese University of Hong Kong

研究负责人通讯地址:

G02, Kwok Sports Building, The Chinese University of Hong Kong

Applicant address:

G02, Kwok Sports Building, The Chinese University of Hong Kong

Study leader's address:

G02, Kwok Sports Building, The Chinese University of Hong Kong

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

The Chinese University of Hong Kong

Applicant's institution:

The Chinese University of Hong Kong

研究负责人所在单位:

The Chinese University of Hong Kong

Affiliation of the Leader:

The Chinese University of Hong Kong

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

SBRE‐25‐0408

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

Survey and Behavioural Research Ethics Committee,The Chinese University of Hong Kong

Name of the ethic committee:

Survey and Behavioural Research Ethics Committee,The Chinese University of Hong Kong

伦理委员会批准日期:

Date of approved by ethic committee:

2025-12-29 00:00:00

伦理委员会联系人:

Mr. Kaki Tang

Contact Name of the ethic committee:

Mr. Kaki Tang

伦理委员会联系地址:

G02, Kwok Sports Building, The Chinese University of Hong Kong

Contact Address of the ethic committee:

G02, Kwok Sports Building, The Chinese University of Hong Kong

伦理委员会联系人电话:

Contact phone of the ethic committee:

+852 3943 6085

伦理委员会联系人邮箱:

Contact email of the ethic committee:

fssc02@cuhk.edu.hk

研究实施负责(组长)单位:

The Chinese University of Hong Kong

Primary sponsor:

The Chinese University of Hong Kong

研究实施负责(组长)单位地址:

G02, Kwok Sports Building, The Chinese University of Hong Kong

Primary sponsor's address:

G02, Kwok Sports Building, The Chinese University of Hong Kong

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

China

省(直辖市):

Hong Kong

市(区县):

Country:

China

Province:

Hong Kong

City:

单位(医院):

The Chinese University of Hong Kong

具体地址:

G02, Kwok Sports Building, The Chinese University of Hong Kong

Institution
hospital:

The Chinese University of Hong Kong

Address:

G02, Kwok Sports Building, The Chinese University of Hong Kong

经费或物资来源:

Agreement for Service with the Otsuka Pharmaceutical (H,K.) Ltd. (TO2520793)

Source(s) of funding:

Agreement for Service with the Otsuka Pharmaceutical (H,K.) Ltd. (TO2520793)

研究疾病:

NA  

Target disease:

NA

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机交叉对照 

Study design:

Cross-over 

研究目的:

The primary objective of this study is to evaluate how the consumption of low-GI and high-GI snack bars influence glucose responses and other physiological parameters during HIIT compared to no food consumption.  

Objectives of Study:

The primary objective of this study is to evaluate how the consumption of low-GI and high-GI snack bars influence glucose responses and other physiological parameters during HIIT compared to no food consumption.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

NA

Exclusion criteria:

NA

研究实施时间:

Study execute time:

From 2026-01-12 00:00:00 To 2026-05-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-01-12 00:00:00 To 2026-01-19 00:00:00

干预措施:

Interventions:

组别:

Low-GI Lentil-Based Snack Bar

样本量:

16

Group:

Low-GI Lentil-Based Snack Bar

Sample size:

干预措施:

Participants will consume a low-GI snack bar (SOYJOY) 60 minutes before performing HIIT. Each condition will be separated by a washout period of 3 days to minimize carryover effects.

干预措施代码:

Intervention:

Participants will consume a low-GI snack bar (SOYJOY) 60 minutes before performing HIIT. Each condition will be separated by a washout period of 3 days to minimize carryover effects.

Intervention code:

组别:

High-GI Snack Bar

样本量:

16

Group:

High-GI Snack Bar

Sample size:

干预措施:

Participants will consume a high-GI snack bar (Snickers Mars) 60 minutes before performing HIIT. Each condition will be separated by a washout period of 3 days to minimize carryover effects.

干预措施代码:

Intervention:

Participants will consume a high-GI snack bar (Snickers Mars) 60 minutes before performing HIIT. Each condition will be separated by a washout period of 3 days to minimize carryover effects.

Intervention code:

组别:

No Food Consumption

样本量:

16

Group:

No Food Consumption

Sample size:

干预措施:

Participants will perform HIIT without consuming any food prior to the session. Each condition will be separated by a washout period of 3 days to minimize carryover effects.

干预措施代码:

Intervention:

Participants will perform HIIT without consuming any food prior to the session. Each condition will be separated by a washout period of 3 days to minimize carryover effects.

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

China

省(直辖市):

Hong Kong 

市(区县):

 

Country:

China

Province:

Hong Kong

City:

单位(医院):

The Chinese University of Hong Kong 

单位级别:

University 

Institution
hospital:

The Chinese University of Hong Kong

Level of the institution:

University

测量指标:

Outcomes:

指标中文名:

Continuous glucose monitoring

指标类型:

主要指标

Outcome:

Continuous glucose monitoring

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Abdominal Discomfort

指标类型:

次要指标

Outcome:

Abdominal Discomfort

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Heart Rate

指标类型:

次要指标

Outcome:

Heart Rate

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Rating of Perceived Exertion

指标类型:

次要指标

Outcome:

Rating of Perceived Exertion

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Enjoyment scale

指标类型:

次要指标

Outcome:

Enjoyment scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Lactate Levels

指标类型:

次要指标

Outcome:

Lactate Levels

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Perceived thirsty

指标类型:

次要指标

Outcome:

Perceived thirsty

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

Blood

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 30 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Participants will be assigned unique identification numbers and then allocated into groups using computer-generated random numbers.

Randomization Procedure (please state who generates the random number sequence and by what method):

Participants will be assigned unique identification numbers and then allocated into groups using computer-generated random numbers.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Assessor blinded

Blinding:

Assessor blinded

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

NA

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

NA

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Electronic Data Capture

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Electronic Data Capture

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-01-04 16:41:09